Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment

References

• Bytzer P, Blum A, De Herdt D, Dubois D. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2004; 20: 181–8
   PubMed Web of Science ®Google Scholar
• Dent J, Holloway RH, Toouli J, Dodds WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gut 1988; 29: 1020–8
   PubMed Web of Science ®Google Scholar
• Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51 Suppl 1: 24–9
   PubMed Web of Science ®Google Scholar
• Cadiot G, Bruhat A, Rigaud D, Coste T, Vuagnat A, Benyedder Y, et al. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut 1997; 40: 167–74
   PubMed Web of Science ®Google Scholar
• van Pinxteren B, Numans ME, Lau J, de Wit NJ, Hungin AP, Bonis PA. Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med 2003; 18: 755–63
   PubMed Web of Science ®Google Scholar
• Miner P. Review article: relief of symptoms in gastric acid-related diseases: correlation with acid suppression in rabeprazole treatment. Aliment Pharmacol Ther 2004; 20 Suppl 6: 20–9
   PubMedGoogle Scholar
• Huang JQ, Hunt RH. pH, healing rate, and symptom relief in patients with GERD. Yale J Biol Med 1999; 72: 181–94
   PubMed Web of Science ®Google Scholar
• Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol 2001; 96 Suppl 8: S57–61
   Google Scholar
• Holtmann G, Bytzer P, Metz M, Loeffler V, Blum AL. A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002; 16: 479–85
   PubMed Web of Science ®Google Scholar
• Bytzer P, Blum AL. Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 20: 389–98
   PubMed Web of Science ®Google Scholar
• McQuaid KR, Laine L. Early heartburn relief with proton pump inhibitors: a systematic review and meta-analysis of clinical trials. Clin Gastroenterol Hepatol 2005; 3: 553–63
   PubMed Web of Science ®Google Scholar
• Besancon M, Simon A, Sachs G, Shin JM. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem 1997; 272: 22438–46
   PubMed Web of Science ®Google Scholar
• Pantoflickova D, Dorta G, Ravic M, Jornod P, Blum AL. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Aliment Pharmacol Ther 2003; 17: 1507–14
   PubMed Web of Science ®Google Scholar
• Armstrong D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J Biol Med 1999; 72: 93–100
   PubMed Web of Science ®Google Scholar
• Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172–80
   PubMed Web of Science ®Google Scholar
• Veldhuyzen van Zanten SJ, Tytgat KM, Pollak PT, Goldie J, Goodacre RL, Riddell RH, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis?. J Clin Epidemiol 1993; 46: 273–9
   PubMed Web of Science ®Google Scholar
• Galmiche JP, Shi G, Simon B, Casset-Semanza F, Slama A. On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo. Aliment Pharmacol Ther 1998; 12: 909–17
   PubMed Web of Science ®Google Scholar
• Faaij RA, Van Gerven JM, Jolivet-Landreau I, et al. Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn. Aliment Pharmacol Ther 1999; 13: 1605–10
   PubMed Web of Science ®Google Scholar
• Castell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 2002; 97: 575–83
   PubMed Web of Science ®Google Scholar
• Warrington S, Baisley K, Boyce M, Tejura B, Morocutti A, Miller N. Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects. Aliment Pharmacol Ther 2002; 16: 1301–7
   PubMed Web of Science ®Google Scholar
• Williams MP, Sercombe J, Hamilton MI, Pounder RE. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther 1998; 12: 1079–89
   PubMed Web of Science ®Google Scholar
• Pace F, Annese V, Prada A, et al. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole. Dig Liver Dis 2005; 37: 741–50
   PubMedGoogle Scholar
• Robinson M. Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders. Aliment Pharmacol Ther 2004; 20 Suppl 6: 30–7
   PubMedGoogle Scholar
• Robinson M, Fitzgerald S, Hegedus R, Murthy A, Jokubaitis L. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther 2002; 16: 445–54
   PubMed Web of Science ®Google Scholar
• Junghard O, Wiklund I. Treatment success defined as heartburn improvement or heartburn resolution in symptomatic GERD patients: evaluation of responsiveness. Gastroenterology 2005; 128 Suppl 2: A285
   Google Scholar
• Johannes C, Woods J, Crawford S, Cochran H, Tran D, Schuth B. Electronic versus paper instruments for daily data collection. Ann Epidemiol 2000; 10: 457
   Google Scholar
• Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with paper diaries. Br Med J 2002; 324: 1193–4
   PubMed Web of Science ®Google Scholar
• Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia?. Gastrointest Endosc 1998; 47: 449–54
   PubMedGoogle Scholar